首页> Circulation> Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease.

Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease.

导出 LinkOut

翻译打印收藏纠错

第一作者： John W,Stanifer

第一单位： Munson Nephrology, Munson Healthcare, Traverse City, MI (J.W.S.).

作者： John W,Stanifer ^[1] ; Sean D,Pokorney ^[2] ; Glenn M,Chertow ^[3] ; Stefan H,Hohnloser ^[4] ; Daniel M,Wojdyla ^[5] ; Samira,Garonzik ^[6] ; Wonkyung,Byon ^[7] ; Ziad,Hijazi ^[8] ; Renato D,Lopes ^[5] ; John H,Alexander ^[2] ; Lars,Wallentin ^[8] ; Christopher B,Granger ^[2]

作者单位： Munson Nephrology, Munson Healthcare, Traverse City, MI (J.W.S.). ^[1] Division of Cardiology, Department of Medicine, Duke Health (S.D.P., J.H.A., C.B.G.), Duke University School of Medicine, Durham, NC.;Duke Clinical Research Institute (S.D.P., D.M.W., R.D.L., J.H.A., C.B.G.), Duke University School of Medicine, Durham, NC. ^[2] Division of Nephrology, Stanford University School of Medicine, CA (G.M.C.). ^[3] Johann Wolfgang Goethe University, Frankfurt, Germany (S.H.H.). ^[4] Duke Clinical Research Institute (S.D.P., D.M.W., R.D.L., J.H.A., C.B.G.), Duke University School of Medicine, Durham, NC. ^[5] Clinical Pharmacology and Pharmacometrics, Bristol-Myers Squibb Company, Princeton, NJ (S.G.). ^[6] Global Product Development Clinical Pharmacology, Pfizer, Inc, Groton, CT (W.B.). ^[7] Department of Medical Sciences, Cardiology, and Uppsala Clinical Research Center (Z.H., L.W.), Uppsala University, Sweden. ^[8]

关键词 apixaban atrial fibrillation renal insufficiency, chronic warfarin